Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8343130 | ENDO VENTURES LTD | Needleless injector |
Oct, 2022
(11 months ago) | |
US8491524 | ENDO VENTURES LTD | Needleless injector drug capsule and a method for filling thereof |
Nov, 2022
(10 months ago) | |
US8241244 | ENDO VENTURES LTD | Needleless injector drug capsule and a method for filling thereof |
Nov, 2022
(10 months ago) | |
US8267903 | ENDO VENTURES LTD | Casing |
Mar, 2023
(6 months ago) | |
US8241243 | ENDO VENTURES LTD | Needleless injector drug capsule and a method for filling thereof |
Aug, 2023
(a month ago) | |
US8118771 | ENDO VENTURES LTD | Needleless injector drug capsule and a method for filling thereof |
Aug, 2023
(a month ago) | |
US8287489 | ENDO VENTURES LTD | Device for readying a needle free injector for delivery |
Dec, 2024
(1 year, 2 months from now) | |
US7901385 | ENDO VENTURES LTD | Casing |
Jul, 2026
(2 years from now) | |
US7776007 | ENDO VENTURES LTD | Device for readying a needle free injector for delivery |
Nov, 2026
(3 years from now) |
Drugs and Companies using SUMATRIPTAN SUCCINATE ingredient
Market Authorisation Date: 15 July, 2009
Treatment: NA
Dosage: INJECTABLE;SUBCUTANEOUS
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic